Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.

Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, Flotte TJ, Duncan LM, Granter SR, Chin L.

Cell. 2006 Jun 30;125(7):1269-81.

2.

NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.

Jin Y, Li F, Zheng C, Wang Y, Fang Z, Guo C, Wang X, Liu H, Deng L, Li C, Wang H, Chen H, Feng Y, Ji H.

Int J Cancer. 2014 May 15;134(10):2294-304. doi: 10.1002/ijc.28568. Epub 2013 Nov 15.

3.

Of mice and men: cancer gene discovery using comparative oncogenomics.

Tomlins SA, Chinnaiyan AM.

Cancer Cell. 2006 Jul;10(1):2-4.

4.

Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.

Labelle-Côté M, Dusseault J, Ismaïl S, Picard-Cloutier A, Siegel PM, Larose L.

BMC Cancer. 2011 Oct 12;11:443. doi: 10.1186/1471-2407-11-443.

5.

Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.

Kondo S, Iwata S, Yamada T, Inoue Y, Ichihara H, Kichikawa Y, Katayose T, Souta-Kuribara A, Yamazaki H, Hosono O, Kawasaki H, Tanaka H, Hayashi Y, Sakamoto M, Kamiya K, Dang NH, Morimoto C.

Clin Cancer Res. 2012 Nov 15;18(22):6326-38. doi: 10.1158/1078-0432.CCR-11-2162. Epub 2012 Oct 4.

6.

Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.

Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, Tepper RI, Shyjan AW.

Cancer Res. 1998 Apr 1;58(7):1515-20.

7.

Cross-species oncogenomics in cancer gene identification.

Peeper D, Berns A.

Cell. 2006 Jun 30;125(7):1230-3.

8.

The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility.

Ahn J, Sanz-Moreno V, Marshall CJ.

J Cell Sci. 2012 Apr 1;125(Pt 7):1814-26. doi: 10.1242/jcs.101444. Epub 2012 Feb 10.

9.

A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.

Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.

Cancer Res. 2000 Oct 15;60(20):5848-56.

10.

Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells.

Klemke M, Rafael MT, Wabnitz GH, Weschenfelder T, Konstandin MH, Garbi N, Autschbach F, Hartschuh W, Samstag Y.

Int J Cancer. 2007 Jun 15;120(12):2590-9.

11.
12.

Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.

Rozenberg GI, Monahan KB, Torrice C, Bear JE, Sharpless NE.

Melanoma Res. 2010 Oct;20(5):361-71. doi: 10.1097/CMR.0b013e328336ee17.

13.

A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.

O'Neill GM, Seo S, Serebriiskii IG, Lessin SR, Golemis EA.

Cancer Res. 2007 Oct 1;67(19):8975-9. Review.

14.

A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.

Little JL, Serzhanova V, Izumchenko E, Egleston BL, Parise E, Klein-Szanto AJ, Loudon G, Shubina M, Seo S, Kurokawa M, Ochs MF, Golemis EA.

Oncogene. 2014 Jan 23;33(4):411-20. doi: 10.1038/onc.2012.607. Epub 2013 Jan 14.

15.

mda-9/Syntenin: a positive regulator of melanoma metastasis.

Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, Randolph A, Valerie K, Sarkar D, Fisher PB.

Cancer Res. 2005 Dec 1;65(23):10901-11.

16.

Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.

Lu P, Wang ZP, Dang Z, Zheng ZG, Li X, Zhou L, Ding R, Yue SQ, Dou KF.

Oncol Rep. 2015 May;33(5):2375-83. doi: 10.3892/or.2015.3863. Epub 2015 Mar 18.

PMID:
25812772
17.

The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC.

Sima N, Cheng X, Ye F, Ma D, Xie X, Lü W.

PLoS One. 2013 Sep 18;8(9):e74594. doi: 10.1371/journal.pone.0074594. eCollection 2013.

18.

S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.

Ikoma N, Yamazaki H, Abe Y, Oida Y, Ohnishi Y, Suemizu H, Matsumoto H, Matsuyama T, Ohta Y, Ozawa A, Ueyama Y, Nakamura M.

Oncol Rep. 2005 Sep;14(3):633-7.

PMID:
16077966
19.

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance.

Sinnberg T, Menzel M, Ewerth D, Sauer B, Schwarz M, Schaller M, Garbe C, Schittek B.

PLoS One. 2011;6(8):e23429. doi: 10.1371/journal.pone.0023429. Epub 2011 Aug 17.

20.

Proinvasion metastasis drivers in early-stage melanoma are oncogenes.

Scott KL, Nogueira C, Heffernan TP, van Doorn R, Dhakal S, Hanna JA, Min C, Jaskelioff M, Xiao Y, Wu CJ, Cameron LA, Perry SR, Zeid R, Feinberg T, Kim M, Vande Woude G, Granter SR, Bosenberg M, Chu GC, DePinho RA, Rimm DL, Chin L.

Cancer Cell. 2011 Jul 12;20(1):92-103. doi: 10.1016/j.ccr.2011.05.025.

Supplemental Content

Support Center